A detailed history of Steward Partners Investment Advisory, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 35,850 shares of MIRM stock, worth $1.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,850
Previous 56,700 36.77%
Holding current value
$1.47 Million
Previous $1.42 Million 13.97%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$23.57 - $34.85 $491,434 - $726,622
-20,850 Reduced 36.77%
35,850 $1.23 Million
Q1 2024

May 15, 2024

BUY
$24.92 - $30.02 $427,378 - $514,843
17,150 Added 43.36%
56,700 $1.42 Million
Q4 2023

Feb 12, 2024

BUY
$27.14 - $34.93 $257,830 - $331,835
9,500 Added 31.61%
39,550 $1.17 Million
Q3 2023

Nov 13, 2023

BUY
$24.63 - $32.85 $518,461 - $691,492
21,050 Added 233.89%
30,050 $949,000
Q2 2023

Aug 14, 2023

SELL
$23.51 - $30.09 $11,755 - $15,045
-500 Reduced 5.26%
9,000 $232,000
Q4 2022

Feb 15, 2023

BUY
$17.59 - $23.83 $37,818 - $51,234
2,150 Added 29.25%
9,500 $185,000
Q3 2022

Nov 10, 2022

BUY
$19.98 - $29.44 $126,873 - $186,944
6,350 Added 635.0%
7,350 $154,000
Q2 2022

Aug 04, 2022

SELL
$18.42 - $27.5 $18,420 - $27,500
-1,000 Reduced 50.0%
1,000 $19,000
Q1 2022

May 02, 2022

SELL
$15.5 - $23.93 $46,500 - $71,790
-3,000 Reduced 60.0%
2,000 $44,000
Q4 2021

Feb 08, 2022

SELL
$13.05 - $19.35 $3,262 - $4,837
-250 Reduced 4.76%
5,000 $80,000
Q3 2021

Nov 12, 2021

BUY
$13.95 - $20.18 $31,387 - $45,405
2,250 Added 75.0%
5,250 $105,000
Q2 2021

Aug 13, 2021

BUY
$15.84 - $20.6 $47,520 - $61,800
3,000 New
3,000 $52,000
Q1 2021

May 14, 2021

SELL
$16.29 - $21.92 $40,725 - $54,800
-2,500 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$15.75 - $25.45 $39,375 - $63,625
2,500 New
2,500 $44,000

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.51B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.